Product Information
SAXAGLIPTIN HCL 5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.1176 per EA under NDC 00378470693. Its NADAC has been published 141 times since Oct 18, 2023.
Strength
5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378470693
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SAXAGLIPTIN HYDROCHLORIDE DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205980On Market Since
8/4/2023
Pharmacological Classes
Price Statistics
The NADAC for SAXAGLIPTIN HCL 5 MG TABLET has been published 141 times since Oct 18, 2023, and over the history we have for it it has declined 31.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1176 per EA |
|---|---|
| All-time high | $6.6735 (Jun 12, 2024) |
| All-time low | $1.1176 (Jun 17, 2026) |
| 52-week high | $5.7097 |
| 52-week low | $1.1176 |
| Median price | $3.4572 |
| Average price | $3.6686 |
| Largest weekly change | +315.1% (Apr 17, 2024) |
| Weeks tracked | 141 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SAXAGLIPTIN HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SAXAGLIPTIN HCL 5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $1.1176 per EA (NDC 00378470693), effective Jun 24, 2026.
How has the price of SAXAGLIPTIN HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for SAXAGLIPTIN HCL 5 MG TABLET has declined 31.4%. It has been tracked across 141 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for SAXAGLIPTIN HCL 5 MG TABLET?
Since Oct 18, 2023, the NADAC for SAXAGLIPTIN HCL 5 MG TABLET has ranged from a low of $1.1176 (Jun 17, 2026) to a high of $6.6735 (Jun 12, 2024), with a median of $3.4572 per EA.
Are there cheaper alternatives to SAXAGLIPTIN HCL 5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SAXAGLIPTIN HCL 5 MG TABLET, but none are currently priced below it.
Who manufactures SAXAGLIPTIN HCL 5 MG TABLET?
SAXAGLIPTIN HCL 5 MG TABLET (NDC 00378470693) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification